International Congress of Antibodies (ICA)
The Annual International Congress of Antibodies (ICA), initiated from 2009, had been successfully organized in Beijing, Hangzhou Dalian, Nanjing, and Miami attracted more than 4,000 participants from 60+ countries. ICA series congresses contribute to offering professionals in the field of antibody a multidisciplinary informative cooperative platform, and it has been the most definite and grand Antibody event in Asia. The ICA-2021 will be held in different cities as Nanjing, Dalian, Macao, Osaka, and Amsterdam, etc.
ICA has become accepted as an influential conference for worldwide antibodies professionals to discuss and develop the latest research breakthroughs as well as potential business opportunities. We hope such a well-designed combinatorial meeting can empower better communication channels for antibody researchers and scientists surrounded by clinicians, epidemiologists, microbiologists, immunologists, molecular biologists, public health officials, representatives from pharmaceutical and biotechnology industries, and policymakers to create a friendly liberal environment to update latest exciting developments in this frontline area to share better research ideas and provide improved therapeutic and preventive solutions to saving and enhancing lives by using antibodies.
ICA has become accepted as an influential conference for worldwide antibodies professionals to discuss and develop the latest research breakthroughs as well as potential business opportunities. We hope such a well-designed combinatorial meeting can empower better communication channels for antibody researchers and scientists surrounded by clinicians, epidemiologists, microbiologists, immunologists, molecular biologists, public health officials, representatives from pharmaceutical and biotechnology industries, and policymakers to create a friendly liberal environment to update latest exciting developments in this frontline area to share better research ideas and provide improved therapeutic and preventive solutions to saving and enhancing lives by using antibodies.
- Designing 100+ Sessions of Scientific Forums, Symposia, Roundtables, Dialogs, Workshops, And Training Courses Covering Top Trends and Advances in Biotherapeutic R & D
- Inviting Worldwide Distinguished Experts, Investors, And Decision Makers in the Areas of Antibody R & D for the Grand Thought Collision from 50+ Countries
- Shooting for 300+ Oral Presentations and Hot Paper Briefing in the Whole Spectrum of Breakthroughs in Biopharmaceutical R & D from both Industry and Academia
- Gathering 50+ Exhibitors in Cutting-Edge Technologies and Novel Bioproducts
- Bring in up to 1000 Distinguished Participants All Together in Fields of Immunotherapy, such as Antibody and Vaccines, Gene Therapy, Cell Therapy and protein therapeutics to Macao
- Bringing in 30+ Professional Media Supporters
- Scheduling 4+ Sessions of Business & Career Development, And Talent Search
- Multi-Zones of Poster Show and Exhibitions of New Finding, New IP, New Tech and New Products
- 2-3 Interactive Events to Enhance the Professional Network and Matchmaking
- One Annual Report Release/Peers Review on Current Trend, Economic Value, Scientific Breakthroughs and Future Directions on Biotherapeutic R & D